Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
BRIEF-Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million Jun 25 (Reuters) - Medexus Pharmaceuticals Q4 net income USD -2.675 million.
- Q4 adjusted EBITDA USD 4.279 million vs. IBES estimate USD 3.47 million
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million